The Medicines (Products Other Than Veterinary Dmgs) (Prescription Only) Amendment Order 1993

• Citation: S.I. 1993/1890
• Sections: 5

Section 1 Citation, commencement and interpretation

(1) This Order may be cited as the Medicines (Products Other Than Veterinary Drugs) (Prescription Only) Amendment Order 1993, and shall come into force on 23rd August 1993.

(2) In this Order— “the principal Order ” means the Medicines (Products Other Than Veterinary Drugs) (Prescription Only) Order 1983 .

Section 2 Amendment of article 3 of the principal Order

In article 3(1)(a) of the principal Order (medicinal products on prescription only), for “Article 4(1), (1A), (1B), (1C), (1D) and (1E)”there is substituted “Article 4(1) to (1J)”.

Section 3 Amendment of article 4 of the principal Order

In article 4 of the principal Order (medicinal products that are not prescription only), the following paragraphs are inserted after paragraph (1E):

(1F) Notwithstanding article 3(1)(a), a medicinal product shall not be a prescription only medicine by reason that it contains the substance acrivastine where—

(a) the medicinal product is sold or supplied in a container or package containing not more than 240 milligrams of acrivastine;

(b) its container or package is labelled to show a maximum daily dose of 24 milligrams of acrivastine.

(1G) Notwithstanding article 3(1)(a), a medicinal product shall not be a prescription only medicine by reason that it contains the substance cetirizine where—

(a) the medicinal product is sold or supplied in a container or package containing not more than 100 milligrams of cetirizine;

(b) its container or package is labelled to show a maximum daily dose of 10 milligrams of cetirizine.

(1H) Notwithstanding article 3(1)(a), a medicinal product shall not be a prescription only medicine by reason that it contains the substance ketoprofen where—

(a) the maximum strength of the ketoprofen in the medicinal product does not exceed two point five per cent.calculated in terms of weight in weight;

(b) the medicinal product is sold or supplied in a container or package containing not more than 30 grams of the medicinal product;

(c) the medicinal product is indicated only for treatment by external topical application, for rheumatic and muscular pain in adults and in children over the age of 12 years, for a maximum period of 7 days.

(1I) Notwithstanding article 3(1)(a), a medicinal product shall not be a prescription only medicine by reason that it contains the substance loratadine where—

(a) the medicinal product is sold or supplied in a container or package containing not more than 100 milligrams of loratadine;

(b) its container or package is labelled to show a maximum daily dose of 10 milligrams of loratadine.

(1J) Notwithstanding article 3(1)(a), a medicinal product shall not be a prescription only medicine by reason that it contains the substance terfenadine where—

(a) the medicinal product is sold or supplied in a container or package containing not more than 1200 milligrams of terfenadine;

(b) its container or package is labelled to show a maximum daily dose of 120 milligrams of terfenadine.

Section 4 Amendment of Part I of Schedule 1 to the principal Order

In Part I of Schedule 1 to the principal Order (which lists substances which render a medicinal product a prescription only medicine except in circumstances also listed) the following substances are inserted at the appropriate points in the alphabetical order of the substances listed in column 1:

Acemetacin

Acitretin

Aclarubicin Hydrochloride

Acrivastine

Adenosine

Albendazole

Aldesleukin

Alfuzosin Hydrochloride

Azithromycin

Bambuterol Hydrochloride

Cefixime

Cefodizime Sodium

Cefpodoxime Proxetil

Celiprolol Hydrochloride

Cetirizine

Cilastatin Sodium

Cilazapril

Ciprofibrate

Clarithromycin

Colfosceril Palmitate

Dalteparin Sodium

Dexfenfluramine Hydrochloride

Diclofenac Potassium

Eflornithine Hydrochloride

Enoxaparin Sodium

Epirubicin Hydrochloride

Epoetin Alfa

Epoetin Beta

Filgrastim

Finasteride

Flosequinan

Fluticasone Propionate

Formestane

Fosfomycin

Trometamol

Fosinopril Sodium

Gadoteridol

Gestrinone

Granisetron Hydrochloride

Guanfacine Hydrochloride

Halofantrine Hydrochloride

Imipenem Hydrochloride

Iomeprol

Iopentol

Iothalamic Acid

Ioversol

Ioxaglic Acid

Ketorolac Trometamol

Lacidipine

Lamotrigine

Lomefloxacin Hydrochloride

Loratadine

Mifepristone

Mivacurium Chloride

Moclobemide

Molgramostim

Mometasone Furoate

Moracizine Hydrochloride

Nafarelin Acetate

Nitrendipine

Norfloxacin

Norgestimate

Ofloxacin

Ondansetron Hydrochloride

Oxaprozin

Oxitropium Bromide

Oxybutynin Hydrochloride

Paroxetine Hydrochloride

Perfluamine

Pergolide Mesylate

Pravastatin Sodium

Remoxipride Hydrochloride

Risperidone

Salmeterol Hydroxynaphthoate

Sermorelin

Sertraline Hydrochloride

Sodium Clodronate

Somatorelin Acetate

Sultamicillin

Sumatriptan Succinate

Tazobactam Sodium

Terfenadine

Tibolone

Tinzaparin

Tolfenamic Acid

Tropisetron Hydrochloride

Tulobuterol

Tulobuterol Hydrochloride

Zuclopenthixol Acetate

Section 5 Amendment of Table A of Part IV of Schedule 1 to the principal Order

In Table A of Part IV of Schedule 1 to the principal Order (medicinal products specified by name and product licence number that are not prescription only medicines), immediately after the entry Zenoxone Ointment 0181/0032 there is inserted the following entry:

Zovirax Cold Sore Cream 0003/0304